J. Hadden
Immuno-Rx
Inc., New York
USA
Name/email consistency: high
- A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck. Hadden, J., Verastegui, E., Barrera, J.L., Kurman, M., Meneses, A., Zinser, J.W., de la Garza, J., Hadden, E. Int. Immunopharmacol. (2003)









